ClinVar Miner

Submissions for variant NM_002693.3(POLG):c.3586G>A (p.Asp1196Asn)

gnomAD frequency: 0.00001  dbSNP: rs765344513
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000188628 SCV000242251 uncertain significance not provided 2024-08-26 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Reported in an individual with developmental delay, short stature, and myopathy (PMID: 18546365); This variant is associated with the following publications: (PMID: 18546365)
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine RCV000758333 SCV000886998 likely benign Progressive sclerosing poliodystrophy 2018-10-01 criteria provided, single submitter clinical testing The NM_002693.2:c.3586G>A (NP_002684.1:p.Asp1196Asn) [GRCH38: NC_000015.10:g.89317433C>T] variant in POLG gene is interpretated to be a Likely Benign based on ACMG guidelines (PMID: 25741868). This variant meets the following evidence codes reported in the ACMG-guideline. BP4:Computational evidence/predictors indicate no impact on the POLG structure, function, or protein-protein interaction. BP6:Reputable source(s) without shared data suggest the variant is benign. Based on the evidence criteria codes applied, the variant is suggested to be Likely Benign.
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001847833 SCV002104877 uncertain significance Hereditary spastic paraplegia 2020-11-25 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000758333 SCV002286752 uncertain significance Progressive sclerosing poliodystrophy 2023-08-10 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 1196 of the POLG protein (p.Asp1196Asn). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on POLG protein function. ClinVar contains an entry for this variant (Variation ID: 206571). This missense change has been observed in individual(s) with clinical features of autosomal dominant POLG-related condition (PMID: 18546365). This variant is present in population databases (rs765344513, gnomAD 0.0009%).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.